Sibutramine — CAS 86168-78-7

Sibutramine is a serotonin–norepinephrine–dopamine reuptake inhibitor originally developed as an anorexiant for obesity management. It acts centrally to suppress appetite and increase satiety signals. Mediocon Inc manufactures GMP-compliant Sibutramine API at its Aurangabad facility to international pharmacopoeial standards.

• Obesity management
• Appetite suppression
• Weight loss therapy
• Metabolic disorder research

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support